ARCHIVES

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

This article is from The Cancer Letter archive.

Vol. 35 No. 15 | April 17, 2009

Download PDF Visit The Full Archive

Related Articles

More Shakeups Coming Cooperative groups; Chairmen Consider Mutimembership Problems

February 20, 1976

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

Arthur James, Ohio Founder Of Research Institute, Dead.

October 26, 2001

Subcommittee chairman Critical Of DCR For Lack Of “Game Plan”

October 28, 1977

DCT Board Okays Kaposi Study, Blocks Monitoring Plan

February 26, 1982

CPT Code Changes Confuse Oncologists, Appear To Bloc Some Chemotherapy Payments

April 6, 1990